Biovet receives CDSCO licence DIVA marker vaccine for lumpy skin disease
BIOLUMPIVAXIN, developed with ICAR, is reportedly India’s first LSD vaccine
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Sanofi India receives marketing authorisation for Rezurock in India
Belumosudil Tablets approved for chronic graft-versus-host disease treatment
We built the CoviRx database through BITS Pilani to help identify drugs that could be repurposed for…
Professor Seshadri Vasan, Honorary Professor of Medical and Health Sciences at Edith Cowan University (Australia) and University…
Lupin and Natco secure US FDA approval for generic Bosentan tablets for oral suspension
Natco receives first-to-file exclusivity for Bosentan Tablets for Oral Suspension, 32 mg, in the US market
India’s pharma exports set to reach $350 billion by 2047, report finds
India’s pharma exports are projected to grow from $27 billion in 2023 to $350 billion by 2047, positioning the nation as a global…
Alkem Laboratories announces strategic acquisitions of Adroit Biomed and Bombay Ortho Industries
Alkem Laboratories acquires 100 per cent stakes in Adroit Biomed and Bombay Ortho Industries for INR 140 crore and INR 147 crore,…
Sun Pharma and Philogen complete patient enrollment for Phase III soft tissue sarcoma trial
Philogen and Sun Pharma announce the completion of patient enrollment in the Phase III FIBROSARC trial for soft tissue sarcoma,…
Areteia’s dexpramipexole holds potential to redefine respiratory health: GlobalData
Oral eosinophilic asthma therapy nears Phase 3 completion, with results set to shape future treatment pathways
India Ratings and Research maintains Neutral Outlook for pharmaceuticals sector in FY26
Revenue growth projected at 9 % -10 % year-on-year; operating margins expected to remain stable
Pharma M&A and venture capital deals reach $33.7 billion in Jan 2025
Johnson & Johnson, Eli Lilly, and Gilead Sciences lead M&A activity; Venture capital investments increase by 62.1 per cent…